Dr. Mesa on Ruxolitinib in Chronic Myeloid Leukemia
1 Pogledi
• 07/08/23
0
0
Ugraditi
administrator
Pretplatnici
Ruben A. Mesa, MD, Professor of Medicine, Division of Hematology & Medical Oncology, Mayo Clinic, discusses the mechanism of action of ruxolitinib in chronic myeloid leukemia.
More on hematologic malignancies: http://www.onclive.com/special....ty/hematologic-cance
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari